Name: 글로벌 시장 동향
SKU: PH1184
Availability: InStock

보고서 요약(국문)

개요
전 세계 순환 종양 세포(CTC) 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) XX%로 성장하여 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
순환 종양 세포(CTC)는 원발성 종양에서 떨어져 나와 말초 혈액 순환계로 침투하여 전이를 일으키는 종양 세포입니다. 임상 검체에서 CTC를 민감하게 검출하는 것은 액체 생검을 통해 암 진단 및 예후 예측에 효과적인 도구로 활용될 수 있습니다.
현재의 CTC 검출 기술은 주로 자성 비드, 미세유체 칩 또는 크기 감응형 미세여과와 같은 바이오마커 기반 플랫폼에 의존하지만, 종양의 이질성으로 인해 검출 감도가 저하될 수 있습니다. 최근에는 1mL의 임상 혈액에서 다양한 상피-간엽 전환(EMT) 하위 집단의 CTC를 포획할 수 있는 표면 전하를 띤 초상자성 나노프로브를 이용한 보다 민감하고 바이오마커에 독립적인 CTC 분리 기술이 개발되었습니다.

시장 동향: 성장 동인 및 제약 요인
암 발병 건수 증가
암 발병 건수 증가는 예측 기간 동안 시장 성장을 견인하는 주요 요인 중 하나입니다. 예를 들어, 미국 국립보건통계센터(NCHS)에 따르면 2023년 미국에서는 1,958,310건의 새로운 암 발병 사례와 609,820건의 암 사망 사례가 발생할 것으로 예상됩니다. 전립선암 발병률은 20년간의 감소세 이후 2014년부터 2019년까지 연평균 3%씩 증가하여 99,000건의 추가 발병 사례가 발생했습니다. 그러나 다른 암의 경우 남성이 여성보다 발병률 추세가 더 양호한 것으로 나타났습니다.
암 발병률이 증가함에 따라 효과적인 암 진단 및 모니터링 도구와 CTC 기반 분석법 및 기술에 대한 수요가 증가하고 있습니다. 이는 시장 참여 기업들에게 CTC의 검출, 계수 및 분자적 특성 분석을 가능하게 하는 혁신적인 제품과 솔루션을 개발할 수 있는 중요한 기회를 제공합니다.

또한, 액체 생검 접근법에 대한 관심 증가로 인해 CTC 기반 기술에 대한 수요가 더욱 증가하고 있는데, 이는 암 환자의 실시간 모니터링을 위한 비침습적 방법을 제공하기 때문입니다.
더 나아가, 순환 종양 세포(CTC) 시장은 CTC 검출 기술의 발전, 신속한 암 진단에 대한 수요 증가, 표적 치료법 개발 등 다양한 요인에 의해 성장하고 있으며, 이러한 요인들은 예측 기간 동안 시장 성장에 기여할 것입니다.
시장 동향: 제약 요인
엄격한 규제 체계, CTC 검출의 기술적 어려움, 비용 절감 조치, 첨단 CTC 기술에 대한 정보 부족, 제품 출시 승인에 소요되는 시간 등 여러 요인이 예측 기간 동안 시장 성장을 저해할 수 있습니다.
세분화 분석
글로벌 순환 종양 세포 시장은 제품 유형, 기술, 응용 분야, 검체, 최종 사용자 및 지역별로 세분화됩니다.

제품 유형 부문 중 기기 부문은 순환 종양 세포(CTC) 시장 점유율의 약 43.5%를 차지했습니다.
기기 부문은 약 43.5%의 점유율을 차지하며 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 이 부문은 CTC 관련 응용 분야에 특화된 기기 개발 및 활용에 중점을 두고 있습니다. 기술적 역량을 강화하고 대량 생산을 용이하게 하기 위해, 시장에는 제조된 유리 마이크로칩이 도입되어 여러 문제점을 해결하고 전반적인 효율성을 향상시키고 있습니다.
예를 들어, 2020년 6월 SCIENION AG와 RareCyte Inc.는 cellenONE이 종양학 응용 분야에서 소량의 모델 순환 종양 세포(CTC)를 정확하게 단일 세포로 분주하는 데 가장 적합한 기기임을 입증했다고 발표했습니다. RareCyte는 SCIENION의 프랑스 자회사인 Cellenion의 다재다능한 기술을 활용하여 혈액 샘플에 미리 정의된 수의 표적 CTC를 정확하고 재현성 있게 투여합니다.

지리적 분석
북미는 2022년 시장 점유율의 약 38.4%를 차지했습니다.
북미는 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다. 이는 해당 지역의 암 발병률 증가, 진단 기술의 발전, 의료 전문가들의 인식 제고 등의 요인이 CTC 시장의 성장에 기여했기 때문입니다. 또한, 탄탄한 의료 인프라와 연구 개발에 대한 상당한 투자는 혁신적인 CTC 검출 및 분석 기술의 발전을 촉진했습니다.
예를 들어, 미국 암 협회(American Cancer Society, Inc.)의 2022년 추산에 따르면, 2022년 미국에서 약 236,740건의 새로운 폐암 환자가 발생할 것으로 예상됩니다. 같은 자료에 따르면, 2022년에는 79,000건의 새로운 신장암 환자가 발생하고 13,920명이 신장암으로 사망할 것으로 예상됩니다. 이러한 높은 암 발병률은 CTC 검출 키트에 대한 수요를 증가시켜 시장 성장을 견인할 것으로 전망됩니다.

COVID-19 영향 분석
COVID-19 팬데믹은 순환 종양 세포(CTC) 시장에 상당한 영향을 미쳤습니다. 팬데믹으로 인해 전 세계 의료 시스템이 마비되면서 암 검진, 진단 및 치료가 지연되었습니다. 이는 CTC 기반 검사 및 기술에 대한 수요에 영향을 미쳤습니다. 또한, 필수적이지 않은 의료 시술에 대한 제한과 의료 시설 방문 감소로 인해 CTC 기반 검사 도입이 줄어들었습니다.

시장 세분화
제품 유형별
• 기기
• 키트 및 분석 키트
• 소모품
기술별
• CTC 검출 및 농축 방법
o 면역 포획
o 크기 기반 분리
o 밀도 기반 분리
o 복합 방법
• CTC 직접 검출 방법
o SERS
o 현미경
o 기타
• CTC 분석
응용 분야별
• 액체 생검
• 연구
• 임상
• 기타
검체별
• 혈액
• 골수
• 기타
최종 사용자별
• 병원
• 클리닉
• 진단 센터
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 기업으로는 Thermo Fisher Scientific Inc, QIAGEN, Fluxion Biosciences, Inc., Greiner Bio One International GmbH, Ikonisys Inc., BioFluidica, Biolidics Limited, Creativ MicroTech Inc., Menarini Silicon Biosystems, StemCell Technologies 등이 있습니다.
주요 개발 사항
 2023년 9월, 연구 및 진단 종양학 시장을 위한 혁신적인 순환 종양 세포(CTC) 진단 솔루션을 제공하는 세계적인 액체 생검 기업인 ANGLE plc는 Portrait™ Flex CTC 분석법 출시를 발표했습니다. 이 분석법은 ANGLE의 Onc-ADaPT™ GCP 준수 연구소에서 서비스 형태로 제공되며, CTC 분석 분야에서 10년 이상의 경력을 보유한 전문가 팀이 수행합니다.

 2023년 7월, 액체 생검 및 단일 세포 기술 분야의 선구자인 메나리니 실리콘 바이오시스템즈(MSB)는 혈류에 순환하는 종양 세포에서 델타 유사 리간드 3(DLL3) 단백질 발현을 검출하는 새로운 CELLSEARCH CTC 연구실 서비스를 출시했다고 발표했습니다. 이 바이오마커는 주로 치료가 어려운 암에서 발현됩니다. MSB의 새로운 연구실 서비스는 미충족 의료 수요가 높은 의료 환경에서 바이오마커의 예후 및 예측 가치를 활용하는 최소 침습 검사 개발의 길을 열어줍니다.
 2021년 5월, ARUP Laboratories는 매사추세츠에 본사를 둔 생명공학 회사 TellBio Inc.와 전략적 계약을 체결하여 이 회사의 TellDx 순환 종양 세포(CTC) 기술을 여러 연구 분야에 활용할 것이라고 발표했습니다.

보고서를 구매해야 하는 이유?

• 제품 유형, 기술, 응용 분야, 검체, 최종 사용자 및 지역별 글로벌 순환 종양 세포 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 식별합니다.

• 모든 세그먼트를 포함한 순환 종양 세포 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 Excel 파일을 제공합니다.

글로벌 순환 종양 세포 시장 보고서는 약 77개의 표, 79개의 그림, 187페이지로 구성됩니다.
주요 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 연구 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Circulating Tumor Cells Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX% during the forecast period 2023-2030.
Circulating tumor cells (CTCs) are tumor cells that shed from the primary tumor and intravasate into the peripheral blood circulation system responsible for metastasis. Sensitive detection of CTCs from clinical samples can serve as an effective tool in cancer diagnosis and prognosis through liquid biopsy.
Current CTC detection technologies mainly reply on biomarker-mediated platforms including magnetic beads, microfluidic chips or size-sensitive microfiltration which can compromise detection sensitivity due to tumour heterogeneity. A more sensitive, biomarker-independent CTCs isolation technique has been recently developed with the surface-charged superparamagnetic nanoprobe capable of different EMT subpopulation CTC capture from 1 mL clinical blood.
Market Dynamics: Drivers and Restraints
Increasing number of cancer cases
The increasing number of cancer cases is one of the significant key factors that help the market to grow during the forecast period. For instance, according to the National Center for Health Statistics. In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Cancer incidence increased for prostate cancer by 3% annually from 2014 through 2019 after two decades of decline, translating to an additional 99,000 new cases; otherwise, however, incidence trends were more favourable in men compared to women.
As cancer prevalence rises, there is a growing need for effective cancer diagnostics and monitoring tools along with CTC-based assays and technologies. This presents a significant opportunity for companies operating in the market to develop innovative products and solutions that enable the detection, enumeration, and molecular characterization of CTCs.
Additionally, the growing interest in liquid biopsy approaches further fuels the demand for CTC-based technologies, as they offer a non-invasive method for real-time monitoring of cancer patients.
Furthermore, the circulating tumor cells market is also driven by various other factors like, advancements in CTC detection technologies, increasing demand for rapid cancer diagnosis, development of targeted therapies and others will also help the market to grow during the forecast period.
Market Dynamics: Restraint
Various factors which hamper the market growth during the forecast period some which are Stringent regulatory framework, technical difficulties in CTC detection, cost containment measures, lack of knowledge about advanced CTC technologies, and time-consuming requirements for product launch approvals.
Segment Analysis
The global circulating tumor cells market is segmented based on product type, technology, application, specimen, end user and region.
The devices segment from the product type segment accounted for approximately 43.5% of the circulating tumor cells market share
The devices from the product type segment accounted for approximately 43.5% and are expected to be dominated during the forecast period. This segment focuses on developing and utilizing devices specifically designed for CTC-related applications. To enhance technical capabilities and facilitate mass production, the market has witnessed the introduction of manufactured glass microchips, which address challenges and improve overall efficiency.
For instance, in June 2020, SCIENION AG and RareCyte Inc. stated that cellenONE proved to be the most appropriate device for accurate single-cell dispensing of low numbers of model circulating tumor cells (CTCs) in oncology applications. RareCyte uses the versatile technology of SCIENIONÕs French subsidiary Cellenion for precise and reproducible dosing of a predefined number of targeted CTCs into blood samples.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to factors like the increasing prevalence of cancer in the region coupled with advancements in diagnostic technologies as well as rising awareness among healthcare professionals has contributed to the flourishing CTCs market. Also, robust healthcare infrastructure, coupled with significant investments in research and development, has paved the way for innovative CTC detection and analysis techniques.
For instance, according to the estimates of the 2022, American Cancer Society, Inc., about 236,740 new cases of lung cancer will be diagnosed in the country in 2022. The same source also states that 79,000 new cases of kidney cancer and 13,920 deaths will be reported in 2022 from kidney cancer. The high burden of cancer is expected to boost the demand for CTC detection kits, thereby driving market growth.
COVID-19 Impact Analysis
The COVID-19 pandemic had a significant impact on the circulating tumor cells market. The pandemic caused disruptions in healthcare systems worldwide, leading to delays in cancer screenings, diagnosis, and treatment. This, in turn, affected the demand for CTC-based tests and technologies. Moreover, restrictions on non-essential medical procedures and reduced patient visits to healthcare facilities resulted in a decline in the adoption of CTC-based assays.
Market Segmentation
By Product Type
• Devices
• Kits & Assays
• Consumables
By Technology
• CTC Detection and Enrichment Method
o Immunocapture
o Size-based separation
o Density-based separation
o Combined methods
• CTC Direct Detection Method
o SERS
o Microscopy
o Others
• CTC Analysis
By Application
• Liquid Biopsy
• Research
• Clinical
• Others
By Specimen
• Blood
• Bone Marrow
• Others
By End User
• Hospitals
• Clinics
• Diagnostic Centers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Thermo Fisher Scientific Inc, QIAGEN, Fluxion Biosciences, Inc., Greiner Bio One International GmbH, Ikonisys Inc., BioFluidica, Biolidics Limited, Creativ MicroTech Inc., Menarini Silicon Biosystems, StemCell Technologies among others.
Key Developments
 In September 2023, ANGLE plc, a world-leading liquid biopsy company with innovative circulating tumor cell (CTC) diagnostic solutions for the research and diagnostic oncology market, stated the launch of its Portrait™ Flex CTC assay. The assay is provided as a service from ANGLE's Onc-ADaPT™ GCP-compliant laboratories and conducted by an expert team with over 10 years of experience in CTC analysis.
 In July 2023, Menarini Silicon Biosystems (MSB), a pioneer in liquid biopsy and single-cell technologies, stated the availability of its new CELLSEARCH CTC lab service to detect the expression of the Delta-Like Ligand 3 (DLL3) protein in tumor cells circulating in the bloodstream. This biomarker is mainly expressed in difficult-to-treat cancers. The new MSB lab service opens the door to the development of further minimally invasive tests that leverage the prognostic and predictive value of biomarkers in medical settings with high unmet needs.
 In May 2021, ARUP Laboratories stated that it had signed a strategic agreement with Massachusetts-based TellBio Inc. to use the development-stage biotechnology company’s TellDx circulating tumor cells (CTCs) technology in several research applications.
Why Purchase the Report?
• To visualize the global circulating tumor cells market segmentation based on product type, technology, application, specimen, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of circulating tumor cells market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global circulating tumor cells market report would provide approximately 77 tables, 79 figures and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by Application
3.4. Snippet by Specimen
3.5. Snippet by End User
3.6. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing number of cancer cases
4.1.1.2. Advancements in CTC detection technologies
4.1.2. Restraints
4.1.2.1. Stringent regulatory approvals
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Pipeline Analysis
5.6. Unmet Needs
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Devices*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Kits & Assays
7.4. Consumables
8. By Technology
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.1.2. Market Attractiveness Index, By Technology
8.2. CTC Detection and Enrichment Method*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. CTC Direct Detection Method
8.4. CTC Analysis
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Liquid Biopsy*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Research
9.4. Clinical
9.5. Others
10. By Specimen
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
10.1.2. Market Attractiveness Index, By Specimen
10.2. Blood*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Bone Marrow
10.4. Others
11. By End User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Clinics
11.4. Diagnostic Centers
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. UK
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.7.1. China
12.5.7.2. India
12.5.7.3. Japan
12.5.7.4. Australia
12.5.7.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. Company Profiles
14.1. Thermo Fisher Scientific Inc *
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. QIAGEN
14.3. Fluxion Biosciences, Inc
14.4. Greiner Bio One International GmbH
14.5. Ikonisys Inc
14.6. BioFluidica
14.7. Biolidics Limited
14.8. Creativ MicroTech Inc
14.9. Menarini Silicon Biosystems
14.10. StemCell Technologies
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us

언급된 주요 기업들

Thermo Fisher Scientific Inc, 4.	Key Developments, QIAGEN, Fluxion Biosciences, Inc, Greiner Bio One International GmbH, Ikonisys Inc, BioFluidica, Biolidics Limited, Creativ MicroTech Inc, Menarini Silicon Biosystems, StemCell Technologies

표 목록 (Tables)

List of Tables

Table 1 Global Circulating Tumor Cells (CTC) Market Value, By Technology, 2025, 2029 & 2033 (US$ Million)

Table 2 Global Circulating Tumor Cells (CTC) Market Value, By Product Type, 2025, 2029 & 2033 (US$ Million)

Table 3 Global Circulating Tumor Cells (CTC) Market Value, By Specimen, 2025, 2029 & 2033 (US$ Million)

Table 4 Global Circulating Tumor Cells (CTC) Market Value, By Application, 2025, 2029 & 2033 (US$ Million)

Table 5 Global Circulating Tumor Cells (CTC) Market Value, By End-User, 2025, 2029 & 2033 (US$ Million)

Table 6 Global Circulating Tumor Cells (CTC) Market Value, By Region, 2025, 2029 & 2033 (US$ Million)

Table 7 Global Circulating Tumor Cells (CTC) Market Value, By Technology, 2025, 2029 & 2033 (US$ Million)

Table 8 Global Circulating Tumor Cells (CTC) Market Value, By Technology, 2022-2033 (US$ Million)

Table 9 Global Circulating Tumor Cells (CTC) Market Value, By Product Type, 2025, 2029 & 2033 (US$ Million)

Table 10 Global Circulating Tumor Cells (CTC) Market Value, By Product Type, 2022-2033 (US$ Million)

Table 11 Global Circulating Tumor Cells (CTC) Market Value, By Specimen, 2025, 2029 & 2033 (US$ Million)

Table 12 Global Circulating Tumor Cells (CTC) Market Value, By Specimen, 2022-2033 (US$ Million)

Table 13 Global Circulating Tumor Cells (CTC) Market Value, By Application, 2025, 2029 & 2033 (US$ Million)

Table 14 Global Circulating Tumor Cells (CTC) Market Value, By Application, 2022-2033 (US$ Million)

Table 15 Global Circulating Tumor Cells (CTC) Market Value, By End-User, 2025, 2029 & 2033 (US$ Million)

Table 16 Global Circulating Tumor Cells (CTC) Market Value, By End-User, 2022-2033 (US$ Million)

Table 17 Global Circulating Tumor Cells (CTC) Market Value, By Region, 2025, 2029 & 2033 (US$ Million)

Table 18 Global Circulating Tumor Cells (CTC) Market Value, By Region, 2022-2033 (US$ Million)

Table 19 North America Circulating Tumor Cells (CTC) Market Value, By Technology, 2022-2033 (US$ Million)

Table 20 North America Circulating Tumor Cells (CTC) Market Value, By Product Type, 2022-2033 (US$ Million)

Table 21 North America Circulating Tumor Cells (CTC) Market Value, By Specimen, 2022-2033 (US$ Million)

Table 22 North America Circulating Tumor Cells (CTC) Market Value, By Application, 2022-2033 (US$ Million)

Table 23 North America Circulating Tumor Cells (CTC) Market Value, By End-User, 2022-2033 (US$ Million)

Table 24 North America Circulating Tumor Cells (CTC) Market Value, By Country, 2022-2033 (US$ Million)

Table 25 South America Circulating Tumor Cells (CTC) Market Value, By Technology, 2022-2033 (US$ Million)

Table 26 South America Circulating Tumor Cells (CTC) Market Value, By Product Type, 2022-2033 (US$ Million)

Table 27 South America Circulating Tumor Cells (CTC) Market Value, By Specimen, 2022-2033 (US$ Million)

Table 28 South America Circulating Tumor Cells (CTC) Market Value, By Application, 2022-2033 (US$ Million)

Table 29 South America Circulating Tumor Cells (CTC) Market Value, By End-User, 2022-2033 (US$ Million)

Table 30 South America Circulating Tumor Cells (CTC) Market Value, By Country, 2022-2033 (US$ Million)

Table 31 Europe Circulating Tumor Cells (CTC) Market Value, By Technology, 2022-2033 (US$ Million)

Table 32 Europe Circulating Tumor Cells (CTC) Market Value, By Product Type, 2022-2033 (US$ Million)

Table 33 Europe Circulating Tumor Cells (CTC) Market Value, By Specimen, 2022-2033 (US$ Million)

Table 34 Europe Circulating Tumor Cells (CTC) Market Value, By Application, 2022-2033 (US$ Million)

Table 35 Europe Circulating Tumor Cells (CTC) Market Value, By End-User, 2022-2033 (US$ Million)

Table 36 Europe Circulating Tumor Cells (CTC) Market Value, By Country, 2022-2033 (US$ Million)

Table 37 Asia-Pacific Circulating Tumor Cells (CTC) Market Value, By Technology, 2022-2033 (US$ Million)

Table 38 Asia-Pacific Circulating Tumor Cells (CTC) Market Value, By Product Type, 2022-2033 (US$ Million)

Table 39 Asia-Pacific Circulating Tumor Cells (CTC) Market Value, By Specimen, 2022-2033 (US$ Million)

Table 40 Asia-Pacific Circulating Tumor Cells (CTC) Market Value, By Application, 2022-2033 (US$ Million)

Table 41 Asia-Pacific Circulating Tumor Cells (CTC) Market Value, By End-User, 2022-2033 (US$ Million)

Table 42 Asia-Pacific Circulating Tumor Cells (CTC) Market Value, By Country, 2022-2033 (US$ Million)

Table 43 Middle East and Africa Circulating Tumor Cells (CTC) Market Value, By Technology, 2022-2033 (US$ Million)

Table 44 Middle East and Africa Circulating Tumor Cells (CTC) Market Value, By Product Type, 2022-2033 (US$ Million)

Table 45 Middle East and Africa Circulating Tumor Cells (CTC) Market Value, By Specimen, 2022-2033 (US$ Million)

Table 46 Middle East and Africa Circulating Tumor Cells (CTC) Market Value, By Application, 2022-2033 (US$ Million)

Table 47 Middle East and Africa Circulating Tumor Cells (CTC) Market Value, By End-User, 2022-2033 (US$ Million)

Table 48 Middle East and Africa Circulating Tumor Cells (CTC) Market Value, By Country, 2022-2033 (US$ Million)

Table 49 Cell Microsystems Inc. (Fluxion Biosciences, Inc.): Overview

Table 50 Cell Microsystems Inc. (Fluxion Biosciences, Inc.): Product Portfolio

Table 51 Cell Microsystems Inc. (Fluxion Biosciences, Inc.): Key Developments

Table 52 STEMCELL Technologies Inc.: Overview

Table 53 STEMCELL Technologies Inc.: Product Portfolio

Table 54 STEMCELL Technologies Inc.: Key Developments

Table 55 Beckman Coulter, Inc.: Overview

Table 56 Beckman Coulter, Inc.: Product Portfolio

Table 57 Beckman Coulter, Inc.: Key Developments

Table 58 Qiagen NV: Overview

Table 59 Qiagen NV: Product Portfolio

Table 60 Qiagen NV: Key Developments

Table 61 Rarecells, Inc.: Overview

Table 62 Rarecells, Inc.: Product Portfolio

Table 63 Rarecells, Inc.: Key Developments

Table 64 ScreenCell: Overview

Table 65 ScreenCell: Product Portfolio

Table 66 ScreenCell: Key Developments

Table 67 Menarini Silicon Biosystems, Inc: Overview

Table 68 Menarini Silicon Biosystems, Inc.: Product Portfolio

Table 69 Menarini Silicon Biosystems, Inc.: Key Developments

Table 70 RareCyte, Inc.: Overview

Table 71 RareCyte, Inc.: Product Portfolio

Table 72 RareCyte, Inc.: Key Developments

Table 73 ANGLE plc: Overview

Table 74 ANGLE plc: Product Portfolio

Table 75 ANGLE plc: Key Developments

Table 76 Thermo Fisher Scientific Inc.: Overview

Table 77 Thermo Fisher Scientific Inc.: Product Portfolio

Table 78 Thermo Fisher Scientific Inc.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 2 Global Circulating Tumor Cells (CTC) Market Share, By Technology, 2024 & 2033 (%)

Figure 3 Global Circulating Tumor Cells (CTC) Market Share, By Product Type, 2024 & 2033 (%)

Figure 4 Global Circulating Tumor Cells (CTC) Market Share, By Specimen, 2024 & 2033 (%)

Figure 5 Global Circulating Tumor Cells (CTC) Market Share, By Application, 2024 & 2033 (%)

Figure 6 Global Circulating Tumor Cells (CTC) Market Share, By End-User, 2024 & 2033 (%)

Figure 7 Global Circulating Tumor Cells (CTC) Market Share, By Region, 2024 & 2033 (%)

Figure 8 Global Circulating Tumor Cells (CTC) Market Y-o-Y Growth, By Technology, 2023-2033 (%)

Figure 9 Enrichment Method Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 10 CTC Direct Detection Method Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 11 CTC Analysis Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 12 Global Circulating Tumor Cells (CTC) Market Y-o-Y Growth, By Product Type, 2023-2033 (%)

Figure 13 Kits & Reagents Product Type in Global Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 14 Devices Product Type in Global Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 15 Global Circulating Tumor Cells (CTC) Market Y-o-Y Growth, By Specimen, 2023-2033 (%)

Figure 16 Blood Specimen in Global Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 17 Bone Marrow Specimen in Global Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 18 Other Specimens in Global Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 19 Global Circulating Tumor Cells (CTC) Market Y-o-Y Growth, By Application, 2023-2033 (%)

Figure 20 Clinical Application in Global Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 21 Research Application in Global Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 22 Global Circulating Tumor Cells (CTC) Market Y-o-Y Growth, By End-User, 2023-2033 (%)

Figure 23 Hospitals and Clinics End-User in Global Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 24 Diagnostic Centers End-User in Global Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 25 Research Facilities End-User in Global Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 26 Other End-Users in Global Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 27 Global Circulating Tumor Cells (CTC) Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 28 North America Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 29 North America Circulating Tumor Cells (CTC) Market Share, By Technology, 2024 & 2033 (%)

Figure 30 North America Circulating Tumor Cells (CTC) Market Share, By Product Type, 2024 & 2033 (%)

Figure 31 North America Circulating Tumor Cells (CTC) Market Share, By Specimen, 2024 & 2033 (%)

Figure 32 North America Circulating Tumor Cells (CTC) Market Share, By Application, 2024 & 2033 (%)

Figure 33 North America Circulating Tumor Cells (CTC) Market Share, By End-User, 2024 & 2033 (%)

Figure 34 North America Circulating Tumor Cells (CTC) Market Share, By Country, 2024 & 2033 (%)

Figure 35 South America Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 36 South America Circulating Tumor Cells (CTC) Market Share, By Technology, 2024 & 2033 (%)

Figure 37 South America Circulating Tumor Cells (CTC) Market Share, By Product Type, 2024 & 2033 (%)

Figure 38 South America Circulating Tumor Cells (CTC) Market Share, By Specimen, 2024 & 2033 (%)

Figure 39 South America Circulating Tumor Cells (CTC) Market Share, By Application, 2024 & 2033 (%)

Figure 40 South America Circulating Tumor Cells (CTC) Market Share, By End-User, 2024 & 2033 (%)

Figure 41 South America Circulating Tumor Cells (CTC) Market Share, By Country, 2024 & 2033 (%)

Figure 42 Europe Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 43 Europe Circulating Tumor Cells (CTC) Market Share, By Technology, 2024 & 2033 (%)

Figure 44 Europe Circulating Tumor Cells (CTC) Market Share, By Product Type, 2024 & 2033 (%)

Figure 45 Europe Circulating Tumor Cells (CTC) Market Share, By Specimen, 2024 & 2033 (%)

Figure 46 Europe Circulating Tumor Cells (CTC) Market Share, By Application, 2024 & 2033 (%)

Figure 47 Europe Circulating Tumor Cells (CTC) Market Share, By End-User, 2024 & 2033 (%)

Figure 48 Europe Circulating Tumor Cells (CTC) Market Share, By Country, 2024 & 2033 (%)

Figure 49 Asia-Pacific Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 50 Asia-Pacific Circulating Tumor Cells (CTC) Market Share, By Technology, 2024 & 2033 (%)

Figure 51 Asia-Pacific Circulating Tumor Cells (CTC) Market Share, By Product Type, 2024 & 2033 (%)

Figure 52 Asia-Pacific Circulating Tumor Cells (CTC) Market Share, By Specimen, 2024 & 2033 (%)

Figure 53 Asia-Pacific Circulating Tumor Cells (CTC) Market Share, By Application, 2024 & 2033 (%)

Figure 54 Asia-Pacific Circulating Tumor Cells (CTC) Market Share, By End-User, 2024 & 2033 (%)

Figure 55 Asia-Pacific Circulating Tumor Cells (CTC) Market Share, By Country, 2024 & 2033 (%)

Figure 56 Middle East and Africa Circulating Tumor Cells (CTC) Market Value, 2022-2033 (US$ Million)

Figure 57 Middle East and Africa Circulating Tumor Cells (CTC) Market Share, By Technology, 2024 & 2033 (%)

Figure 58 Middle East and Africa Circulating Tumor Cells (CTC) Market Share, By Product Type, 2024 & 2033 (%)

Figure 59 Middle East and Africa Circulating Tumor Cells (CTC) Market Share, By Specimen, 2024 & 2033 (%)

Figure 60 Middle East and Africa Circulating Tumor Cells (CTC) Market Share, By Application, 2024 & 2033 (%)

Figure 61 Middle East and Africa Circulating Tumor Cells (CTC) Market Share, By End-User, 2024 & 2033 (%)

Figure 62 Cell Microsystems Inc. (Fluxion Biosciences, Inc.): Financials

Figure 63 STEMCELL Technologies Inc.: Financials

Figure 64 Beckman Coulter, Inc.: Financials

Figure 65 Qiagen NV: Financials

Figure 66 Rarecells, Inc.: Financials

Figure 67 ScreenCell: Financials

Figure 68 Menarini Silicon Biosystems, Inc: Financials

Figure 69 RareCyte, Inc.: Financials

Figure 70 ANGLE plc: Financials

Figure 71 Thermo Fisher Scientific Inc.: Financials

세계 순환 종양 세포 시장 – 2023-2030

Global Circulating Tumor Cells Market - 2023-2030